Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662

NCT02194244 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: RG1662 granules
DRUG: RG1662 tablet

Sponsor

Hoffmann-La Roche